Robert De Jager
Impact in
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
Papers in
-
- Cancer therapeutics and mechanisms 7
- Angiogenesis and VEGF in Cancer 4
- Oncology 16
- Cancer Treatment and Pharmacology 7
- Colorectal Cancer Treatments and Studies 4
- Co-authors
- Gerhard Zugmaier (4 shared papers)Cornelius Knabbe (3 shared papers)Theresa A. Zesiewicz (2 shared papers)Roland E. Kontermann (1 shared paper)Dirk M. Nettelbeck (1 shared paper)K. Havemann (3 shared papers)Patrick Jimonet (1 shared paper)U. Schauer (4 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (4 papers)British Journal of Cancer (3 papers)Journal of Clinical Oncology (3 papers)International Journal of Cancer (2 papers)Allergy (2 papers)
- Partner nations
- GermanyUnited StatesBelgium
In The Last Decade
Robert De Jager
50 papers receiving 982 citations
Peers
Comparison fields: 5 of 109
- Immunology and Allergy 75
- Oncology 267
- Toxicology 30
- Molecular Biology 468
- Cancer Research 100
Countries citing papers authored by Robert De Jager
This map shows the geographic impact of Robert De Jager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert De Jager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert De Jager more than expected).
Fields of papers citing papers by Robert De Jager
This network shows the impact of papers produced by Robert De Jager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert De Jager. The network helps show where Robert De Jager may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert De Jager, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 107 | |
| 2 | 2018 | 73 | |
| 3 | 1991 | 68 | |
| 4 | 1996 | 66 | |
| 5 | 2006 | 54 | |
| 6 | 1984 | 48 | |
| 7 | 2003 | 46 | |
| 8 | 2016 | 43 | |
| 9 | 2002 | 41 | |
| 10 | 1993 | 34 | |
| 11 | 1997 | 33 | |
| 12 | Strategies for designing GPCR-focused libraries and screening sets. | 2004 | 33 |
| 13 | 2000 | 32 | |
| 14 | 2001 | 32 | |
| 15 | 2016 | 30 | |
| 16 | 1991 | 25 | |
| 17 | Phase II study of elliptinium in advanced breast cancer. | 1985 | 24 |
| 18 | 1979 | 22 | |
| 19 | 2005 | 20 | |
| 20 | 1995 | 17 |
About Robert De Jager
Robert De Jager is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Surgery and Physiology, having authored 52 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Cancer therapeutics and mechanisms (7 papers), Asthma and respiratory diseases (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Neuroendocrine Tumor Research Advances (4 papers), Testicular diseases and treatments (3 papers) and Gastric Cancer Management and Outcomes (3 papers). The work is most often cited by research in Immunology and Allergy (75 citations), Oncology (267 citations), Toxicology (30 citations), Molecular Biology (468 citations) and Cancer Research (100 citations). Robert De Jager has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include Gerhard Zugmaier, Cornelius Knabbe, Theresa A. Zesiewicz, Roland E. Kontermann, Dirk M. Nettelbeck, K. Havemann, Patrick Jimonet, U. Schauer, C. Rieger and Andreas Neubauer. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, British Journal of Cancer, Journal of Clinical Oncology, International Journal of Cancer and Allergy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.